MD1-05. The Stura Footprint Combination (MD1-20 & MD1-22)

Similar documents
The Stura Footprint Combination HT-96 MD1-43 Rapidly analyse the crystallization potential of your protein and protein complexes.

MultiXtal Formulation

Structure Screen 1 & 2 HT-96 Eco Screen

MD1-38 is presented as a 96 x 10 ml condition targeted sparse matrix screen.

MemMeso TM MD1-86. MemMeso TM A 96-condition crystallization screen specifically for use with mesophases. (LCP compatible). Features of MemMeso:

MD1-32 is presented as 96 x 1 ml conditions in a deep-well block.

Typical ph conditions used for membrane protein crystallization. Total concentration of salts used for membrane protein crystallization.

MD1-60 is presented as 96 x 1 ml conditions in a deep-well block.

MemGold TM. MD1-39 is presented as 96 x 10 ml conditions.

MD1-64-GREEN is a targeted sparse matrix presented as a 96 x 1 ml deep-well block.

The PGA Screen TM HT-96. The kit contains 96 1ml conditions in a deep-well block.

Membrane Proteins. MemGoldMeso 10 ml and HT-96* MD1-114, MD1-115

Clear Strategy TM Screen I HT-96 A 6 4 matrix screen 1 that offers a more rational, logical and flexible approach to crystallization experiments.

MIDASplus MD MD1-106 is presented as 96 x 10 ml conditions.

MD1-74-ECO. MemGold Eco Screen Combo Value Pack (MD1-39-ECO & MD1-63-ECO)

The original systematic screen for membrane proteins.

CryoProtX MD1 61. MD1-61 is presented as a 46 x 1.5 ml kit. To be used in conjunction with the Quick-Start Guide. Features of CryoProtX :

PACT premier,* HT-96 MD1-36. PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen environment.

CryoProtX TM Eco Screen

moleculardimensions.com

Multicomponent cryoprotectant solutions (CM1-CM18)

User Guide HR2-451 (pg 1)

Membrane and Soluble Proteins

MD1-46 is presented as 96 x 10 ml conditions.

Morpheus III 10 ml and HT-96 Screen

Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity

MD1-76. Power Combo Value Pack (MD1-46 & MD1-59)

PACT premier TM HT-96 MD1-36 PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen.

MD1-46 is presented as 96 x 10 ml conditions.

Morpheus TM MD1 46/MD1 47

RUBIC Additive Screen MD1-97 For stable, happy proteins From purification all the way through to characterization by NMR, SAXS or Crystallography.

Crystallisation Conditions The good, the bad and those with special challenges

Nature Protocols: doi: /nprot Supplementary Figure 1

Material Safety Data Sheet

Designing successful membrane protein crystallisation screens: how we designed MemGold. Simon Newstead

The Morpheus Additive Screen

CORESTA Recommended Method No. 85

Manufacturer of High Purity Chemicals PRODUCT LIST

Membrane and Soluble Proteins

Crystal Screens. JBScreen Family JBScreen Formulations. Crystallography

Date Updated: 10/14/2003

U.S. Pharmacopeia Methods for HPLC

Supporting Information for. Patterned Paper as a Platform for Inexpensive, Low Volume, Portable Bioassays

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

UV Tracer TM Maleimide NHS ester

Official Journal of the European Communities. (Acts whose publication is obligatory) COMMISSION DIRECTIVE 2002/82/EC. of 15 October 2002

B. 15 mm Ouabain Solution (Ouabain) (Prepare 10 ml in Reagent A using Ouabain Octahydrate, Sigma Prod. No. O3125.)

TECHNICAL BULLETIN. MDR1, human recombinant, expressed in Sf9 cells, membrane preparation, for ATPase. Product Number M9194 Storage Temperature 70 C

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

1.2 Systematic Name: Orthophosphoric-monoester phosphohydrolase (alkaline optimum)

Enzymatic Assay of PYRUVATE OXIDASE (EC ) from Pediococcus species

Reagent Set DAS ELISA, Alkaline phosphatase label

Glucose Cl NaCl K 2.5

Challenges with Chelated &/or Complexed Minerals (Chelated and Soluble Methods of Analysis Used in FL)

B. 50 mm Calcium Chloride Solution (CaCl 2 ) (Prepare 25 ml in Reagent A using Calcium Chloride, Dihydrate, Sigma Prod. No. C-3881.

TRACP & ALP double-stain Kit

Fatty Acid Oxidation Assay on the XF24 Analyzer

Enzymatic Assay of POLYGALACTURONASE (EC )

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

BabyBio IMAC columns DATA SHEET DS

PhosFree TM Phosphate Assay Biochem Kit

Optimization of a LanthaScreen Kinase assay for CSF1R (FMS)

B. 1% (w/v) Salicin Substrate Solution (Salicin) (Prepare 50 ml in Reagent A using Salicin, Sigma Prod. No. S-0625.)

Enzymatic Assay of RIBONUCLEIC ACID POLYMERASE 1 (EC )

HRP cytochemistry. Division of Radiooncology, Deutsches Krebsforschungszentrum, Heidelberg, Germany

THE UNIVERSITY OF NEWCASTLE- DISCIPLINE OF MEDICAL BIOCHEMISTRY

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Biochemical Techniques 06 Salt Fractionation of Proteins. Biochemistry

Hosta virus X ELISA KIT

B. 100 mm L-Glutamate Solution (L-Glu) (Prepare 2 ml in deionized water using L-Glutamic Acid, Monosodium Salt, Sigma Prod. No. G-1626.

Enzymatic Assay of ß-GLUCOSIDASE (EC )

1. IDENTIFICATION OF SUBSTANCE AND COMPANY DETAILS

In situ proteolysis for protein crystallization and structure determination

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

1. IDENTIFICATION OF SUBSTANCE AND COMPANY DETAILS

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.

Glycosyltransferase Activity Kit

Appendix A: Preparation of Media and Chemicals. Malt Extract Agar (MEA) weighing g was dissolved in 400 ml of distilled water

Revision Bulletin 23 Feb Mar 2018 Chemical Medicines Monographs 3 Compliance

Optimization of a LanthaScreen Kinase assay for ZAP70

SECTION 1: Identification of the substance/mixture and of the company/undertaking

Enzyme Immunoassay for

Laboratorios CONDA, S.A. Distributed by Separations

Aspergillus foetidus BY AQUEOUS TWO PHASE

MRP2 TR ATPase Assay Protocol CAT. NO. SBAT03

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

Chemicals (E) With the partnership of LACH:NER a Czech chemical company

PVY Reagent Set Compound ELISA, Alkaline phosphatase label Potato virus Y Catalog number: SRA 20001

Malachite Green Phosphate Assay Kit. Item No

IVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.

Enzymatic Assay of FRUCTOSE-6-PHOSPHATE KINASE, PYROPHOSPHATE DEPENDENT (EC ) from Mung Bean

1 out of 8. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting 2018 ERYTHROSINE

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Dudley Chemical Corporation

Heparin Sodium ヘパリンナトリウム

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

Transcription:

MD1-05 The Stura Footprint Combination (MD1-20 & MD1-22)

The Stura Footprint Screen MD1-20 Rapidly analyse the crystallization potential of your protein and protein complexes. The footprint screens are based on the concept of screening the protein precipitant solubility curve to analyse the crystallization potential of proteins and their complexes. MD1-20 is presented as two sets of 24 conditions (10 ml) at acidic, neutral and basic ph's for polyethylene glycols and salts. Features of The Stura Footprint Screen: Rapidly analyse the crystallization potential of your protein and protein complexes. Test the relative protein solubility with precipitants that have been used successfully in the crystallization of many proteins. Compare solubility of macromolecules and their complexes. In cases where the amount of protein is limited a systematic approach based on an a priori choice of precipitant may be preferable to an extensive search with sparse matrices or factorial approaches. The Reverse Screening Technique 3 can be applied in such situations. The solutions provided in the Footprint screens may be utilised to assist in making that a priori choice of precipitant. A good companion screen to Macrosol (MD1-22). Introduction A simple screening method to analyse the crystallization potential of proteins and their complexes has been described by Enrico Stura 1. This method is described as the First Footprint as it defines the individual pattern of solubility for a given protein with a range of precipitants and enables the researcher to characterize the types of oils or precipitates obtained. The test is fast and easy to perform as a vapour diffusion experiment. It is highly accurate and reproducible; provided the normal precautions are taken to control the ambient temperature of the experiment. The First Footprint screen is limited to three ph values (5.5, 7.0, and 8.50) and two precipitant classes (PEGs and salts) at four concentrations. A PEG Footprint screen to compliment the original Footprint Screen has subsequently been described 2. This Footprint screen covers six ph values (4.5 8.2) with six PEG s at four concentrations. Crystals of wild-type human transthyretin (TTR) obtained under various crystallization conditions from the Stura Footprint (Molecular Dimensions, Ltd) in the absence of any ligand. (A) Crystals obtained from 33% PEG-600, 0.2 M imidazole malate, ph 5.5. (B) Crystals from 2 M ammonium sulphate, 0.15 M sodium citrate, ph 5.5. (C) Shower of crystals from 1.5 M sodium citrate 10 mm sodium borate, ph 8.5. Larger crystals can be obtained by lowering the precipitant concentration. (D) Crystal grow in small attached blocks from 27% PEG 10,000, 0.1 M ammonium acetate, ph 4.5 (E) Feather-like crystals grow from 60% monomethyl PEG 550, 0.1 M HEPES, ph 8.2. (F) Large prismatic crystals are obtained from 36% monomethyl PEG 5,000, 0.1 M sodium acetate, ph 5.5. 1

How to use: This screen can be set up in full if protein supply is not at a premium. Otherwise proteins generally respond well to 1A, 2B, 3A, 4B, 5A, 6B. A rapid method for using the Footprint solubility screen (with limited amounts of protein). On the first day set up drop 2C of Footprint Screen #1: dispense the protein (1µl) onto the coverslip/microbridge add the precipitant (1µl). Do not mix. Go immediately to the microscope. As the precipitant and the protein mix together the protein will experience locally the final precipitant concentration. You should see some precipitation within 5 mins. If you see too much precipitate set up 2B and repeat. If after 10 minutes there is absolutely no precipitate, consider setting up 2D or concentrating your protein more. Given that you see some precipitate but not an excessive amount continue to set up 1C, 3C-5C, and 6B of Footprint #1 and/or row 1A, 2B, 3A, 4B, 5A, 6B, of the PEG screen. On the second day set up higher or lower concentrations depending on the results. Further drops may be set up with PEG at different ph levels to evaluate the change in solubility with ph. While solubility screening with PEG is normally instantaneous, salts will require equilibration for at least 8 hours. Note: When perfecting your crystallization conditions it is more accurate to mix 30% of 2B with 70% of 2C rather than mixing a new solution at the intermediate concentration. Formulation Notes: The Stura FootPrint screen reagents are formulated using ultrapure water (>18.0 MΩ) and are sterilefiltered using 0.22 µm filters. No preservatives are added. Final ph may vary from that specified on the datasheet. Molecular Dimensions will be happy to discuss the precise formulation of individual reagents. Individual reagents and stock solutions for optimization are available from Molecular Dimensions. Enquiries regarding formulation, interpretation of results or optimization strategies are welcome. Please e-mail, fax or phone your query to Molecular Dimensions. Contact and product details can be found at www.moleculardimensions.com References 1. Stura E.A., Nemerow G.R., Wilson I.A (1992) Strategies in the crystallization of glycoproteiens and protein complexes. Journal of Crystal Growth 122:273-285. 2. Stura E.A. (1999) Strategy 3: Reverse Screening. In Crystallization of Proteins: Techniques, Strategies and Tips. A laboratory manual (Bergfors T. ed.) International University Line pp113-124. 3. Stura E.A, Satterthwait, A.C, Calvo, J.C, Kaslow, D.C, Wilson, I.A. (1994) Reverse Screening. Acta Cryst. D50 : 448-455. Once initial crystals or crystalline aggregates are obtained from the initial screening, streak seeding is recommended to determine the ranges of conditions under which crystal growth can proceed. 2

Stura Footprint Screen #1 1 2 3 4 5 6 PEG 600 PEG 4K PEG 10K NH 4 SO 4 PO 4 Citrate A 15% 10% 7.5% 0.75M 0.8M 0.75M B 24% 15% 12.5% 1.0M 1.32M 1.0M C 33% 20% 17.5% 1.5M 1.6M 1.2M D 42% 25% 22.5% 2.0M 2.0M 1.5M 0.2 M Imidazole malate ph 5.5 0.2 M Imidazole malate ph 7.0 0.2 M Imidazole malate ph 8.5 0.15 M Sodium citrate ph 5.5 Stura PEG Footprint Screen #2 NaH 2 PO 4 K 2 HPO 4 ph 7.0 10 mm Sodium borate ph 8.5 1 2 3 4 5 6 PEG 500 MME PEG 600 PEG 2K MME PEG 4K PEG 5K MME PEG 10K A 30% 18% 18% 8% 12% 9% B 40% 27% 27% 15% 18% 15% C 50% 36% 36% 20% 24% 22.5% D 60% 45% 45% 30% 36% 27% 0.1 M Na HEPES ph 8.2 0.1 M Na HEPES ph 7.5 0.1 M Sodium cacodylate ph 6.5 0.2 M Imidazole malate ph 6.0 0.1 M Sodium acetate ph 5.5 0.1 M Ammonium acetate ph 4.5 Stura PEG Footprint Screen This screen can be set up in full if protein supply is not at a premium. Otherwise proteins generally respond well to 1A, 2B, 3A, 4B, 5A, 6B. Column 4 allows a direct comparison to be made to results obtained with Footprint screen #1 above. The buffers in the other columns have been chosen to be compatible with the use of divalent metals. 3

Stura Footprint Screen Conditions 1-48 MD1-20 Footprint Screen #1 Tube # Conc. Salt Conc. Buffer ph Conc. Precipitant Plate position 1-1 0.2 M Imidazole malate 5.5 15 % v/v PEG 600 1A 1-2 0.2 M Imidazole malate 5.5 24 % v/v PEG 600 1B 1-3 0.2 M Imidazole malate 5.5 33 % v/v PEG 600 1C 1-4 0.2 M Imidazole malate 5.5 42 % v/v PEG 600 1D 1-5 0.2 M Imidazole malate 7.0 10 % w/v PEG 4000 2A 1-6 0.2 M Imidazole malate 7.0 15 % w/v PEG 4000 2B 1-7 0.2 M Imidazole malate 7.0 20 % w/v PEG 4000 2C 1-8 0.2 M Imidazole malate 7.0 25 % w/v PEG 4000 2D 1-9 0.2 M Imidazole malate 8.5 7.5 % w/v PEG 10,000 3A 1-10 0.2 M Imidazole malate 8.5 12.5 % w/v PEG 10,000 3B 1-11 0.2 M Imidazole malate 8.5 17.5 % w/v PEG 10,000 3C 1-12 0.2 M Imidazole malate 8.5 22.5 % w/v PEG 10,000 3D 1-13 0.75 M Ammonium sulfate 0.15 M Sodium citrate 5.5 4A 1-14 1.0 M Ammonium sulfate 0.15 M Sodium citrate 5.5 4B 1-15 1.5 M Ammonium sulfate 0.15 M Sodium citrate 5.5 4C 1-16 2.0 M Ammonium sulfate 0.15 M Sodium citrate 5.5 4D 1-17 0.8 M Potassium/sodium phosphate 7.0 5A 1-18 1.32 M Potassium/sodium phosphate 7.0 5B 1-19 1.6 M Potassium/sodium phosphate 7.0 5C 1-20 2.0 M Potassium/sodium phosphate 7.0 5D 1-21 0.75 M Sodium citrate tribasic dihydrate 0.01 M Sodium borate 8.5 6A 1-22 1.0 M Sodium citrate tribasic dihydrate 0.01 M Sodium borate 8.5 6B 1-23 1.2 M Sodium citrate tribasic dihydrate 0.01 M Sodium borate 8.5 6C 1-24 1.5 M Sodium citrate tribasic dihydrate 0.01 M Sodium borate 8.5 6D Footprint Screen #2 Tube # Conc. Salt Conc. Buffer ph Conc. Precipitant Plate position 2-1 0.1 M Sodium HEPES 8.2 30 % v/v PEG 500 MME 1A 2-2 0.1 M Sodium HEPES 8.2 40 % v/v PEG 500 MME 1B 2-3 0.1 M Sodium HEPES 8.2 50 % v/v PEG 500 MME 1C 2-4 0.1 M Sodium HEPES 8.2 60 % v/v PEG 500 MME 1D 2-5 0.1 M Sodium HEPES 7.5 18 % v/v PEG 600 2A 2-6 0.1 M Sodium HEPES 7.5 27 % v/v PEG 600 2B 2-7 0.1 M Sodium HEPES 7.5 36 % v/v PEG 600 2C 2-8 0.1 M Sodium HEPES 7.5 45 % v/v PEG 600 2D 2-9 0.1 M Sodium cacodylate 6.5 18 % w/v PEG 2000 MME 3A 2-10 0.1 M Sodium cacodylate 6.5 27 % w/v PEG 2000 MME 3B 2-11 0.1 M Sodium cacodylate 6.5 36 % w/v PEG 2000 MME 3C 2-12 0.1 M Sodium cacodylate 6.5 45 % w/v PEG 2000 MME 3D 2-13 0.2 M Imidazole malate 6.0 8 % w/v PEG 4000 4A 2-14 0.2 M Imidazole malate 6.0 15 % w/v PEG 4000 4B 2-15 0.2 M Imidazole malate 6.0 20 % w/v PEG 4000 4C 2-16 0.2 M Imidazole malate 6.0 30 % w/v PEG 4000 4D 2-17 0.1 M Sodium acetate 5.5 12 % w/v PEG 5000 MME 5A 2-18 0.1 M Sodium acetate 5.5 18 % w/v PEG 5000 MME 5B 2-19 0.1 M Sodium acetate 5.5 24 % w/v PEG 5000 MME 5C 2-20 0.1 M Sodium acetate 5.5 36 % w/v PEG 5000 MME 5D 2-21 0.1 M Ammonium acetate 4.5 9 % w/v PEG 10,000 6A 2-22 0.1 M Ammonium acetate 4.5 15 % w/v PEG 10,000 6B 2-23 0.1 M Ammonium acetate 4.5 22.5 % w/v PEG 10,000 6C 2-24 0.1 M Ammonium acetate 4.5 27 % w/v PEG 10,000 6D 4

Abbreviations: Sodium HEPES; 2-(4-(2-Hydroxyethyl)-1-piperazinyl)ethanesulfonic Acid Sodium Salt, MME; monomethyl ether, PEG; Polyethylene glycol. Manufacturer s safety data sheets are available from our website or by scanning the QR code here: Ordering details: Catalogue Description Catalogue Code The Stura Footprint Screen (48 x 10 ml) MD1-20 The Stura Footprint Combination (96 x 10 ml) MD1-05 (The Stura Footprint Screen + Macrosol) The Stura Footprint Combination HT96 (96 x 1 ml) MD1-43 The Stura Footprint Screen Eco Screen (48 x 10 ml) MD1-20-ECO The Stura Footprint Combination Eco Screen (96 x 10 ml) MD1-05-ECO (The Stura Footprint Screen + Macrosol) The Stura Footprint Combination HT96 (96 x 1 ml) MD1-43-ECO Eco Screen Macrosol (48 x 10 ml) MD1-22 Macrosol Eco Screen (48 x 10 ml) MD1-22-ECO Single Reagents The Stura Footprint Screen (100 ml) MDSR-20 - tube number Macrosol (100 ml) MDSR-22 - tube number The Stura Footprint Combination (100 ml) MDSR-43 - well number For Stura Footprint stock reagents visit our Optimization page on our website. 5

MacroSol MD1-22 A crystallization screen for the crystallization of protein complexes and other samples with heterogenous solubility - Screens the protein precipitant solubility curve. The screens are presented as two sets of 24 conditions (10 ml) at acidic, neutral and basic ph's for polyethylene glycols and salts. Features of MacroSol: Screens the protein precipitant solubility curve. Test the relative protein solubility with precipitants that have been used successfully in the crystallization of many proteins. Once initial crystals or crystalline aggregates are obtained from the initial screening, streak seeding is recommended to determine the ranges of conditions under which crystal growth can proceed. Introduction MacroSol is a footprint-type screen based on reagents of proven success in crystallizing glycoproteins and macromolecular complexes. MacroSol is based on the concept of screening the protein precipitant solubility curve. Crystallization of complexes When crystallizing complexes, each of the macromolecules that compose the complex will have a different solubility. It is therefore important to find out where each of the macromolecules precipitates as well as determining the precipitation points for the complex. Screening under multiple conditions is important in these cases, in particular when the exact stoichiometry for the complex is unknown or the complex has been mixed from the individual solutions rather than purified as a complex. Depending on how much excess of one particular macromolecule is present in the solution we will find some precipitation under the condition for that uncomplexed macromolecule Hence screening under multiple conditions is needed for complexes, but also for glycoproteins and proteins obtained from limited proteolysis where heterogeneity in the protein will be reflected in solubility differences. A simple screening method to analyse the crystallization potential of proteins and their complexes has been described by Enrico Stura (1). This method is described as a Footprint as it defines the individual pattern of solubility for a given protein with a range of precipitants and enables the researcher to characterize the types of oils or precipitates obtained. The test is fast and easy to perform as a vapour diffusion experiment. It is highly accurate and reproducible; provided the normal precautions are taken to control the ambient temperature of the experiment. Once initial crystals or crystalline aggregates are obtained from the first screening, streak seeding is recommended to determine the ranges of conditions under which crystal growth can proceed. 1

Formulation Notes MacroSol reagents are formulated using ultrapure water (>18.0 MΩ) and are sterile-filtered using 0.22 μm filters. No preservatives are added. Molecular Dimensions will be happy to discuss the precise formulation of individual reagents. Individual reagents and stock solutions for optimisation are available from Molecular Dimensions. Enquiries regarding MacroSol Screen formulation, interpretation of results or optimisation strategies are welcome. Please e-mail, fax or phone your query to Molecular Dimensions. References 1. Stura E.A., Nemerow G.R., Wilson I.A (1992) Strategies in the crystallization of glycoproteiens and protein complexes. Journal of Crystal Growth 122:273-285 2. Stura E.A. (1999) Strategy 3: Reverse Screening. In Crystallization of Proteins: Techniques, Strategies and Tips. A laboratory manual (Bergfors T. ed.) International University Line pp113-124. 3. Stura E.A, Satterthwait, A.C, Calvo, J.C, Kaslow, D.C, Wilson, I.A. (1994) Reverse Screening. Acta Cryst. D50 : 448-455. 4. Stura E.A, at the "EMBO Workshop on the crystallization of Macromolecular Complexes" Grenoble 8-13 April 2001 Re-Ordering details: Catalogue Description Pack size Catalogue Code MacroSol Screen 48 x 10 ml MD1-22 Stura Footprint Screen 48 x 10 ml MD1-20 The Stura Footprint Combination 96 x 10 ml MD1-05 (MacroSol and Stura Footprint screen) The Stura Footprint Combination HT96 96 x 1 ml MD1-43 (HT-96 version of MacroSol and Stura Footprint screen) ECO Screens The Stura Footprint Combination 96 x 1 ml MD1-05-ECO MacroSol Eco Screen 48 x 10 ml MD1-22-ECO Stura Footprint Eco Screen 48 x 10 ml MD1-20-ECO The Stura Footprint Combination HT96 96 x 1 ml MD1-43-ECO Single Reagents MacroSol single reagents 100 ml MDSR-22-tube number Stura Footprint Screen single reagents 100 ml MDSR-20-tube number The Stura Footprint Combination HT96 100 ml MDSR-43-wellnumber For MacroSol screen stock solutions please visit the Optimization section on our website. 2

MacroSol Screen MD1-22 Tube # Conc. Salt1 Conc. Salt2 Conc. Buffer ph Conc. Precipitant1 Conc. Precipitant2 1-1 0.02 M Calcium chloride dihydrate 0.1 M Sodium acetate 4.5 10 % v/v MPD 1-2 0.02 M Calcium chloride dihydrate 0.1 M Sodium acetate 4.5 20 % v/v MPD 1-3 0.1 M Sodium acetate 4.5 30 % v/v MPD 1-4 0.02 M Calcium chloride dihydrate 0.1 M Sodium acetate 4.5 30 % v/v MPD 1-5 0.1 M Sodium phosphate monobasic monohydrate 1.0 M Sodium acetate trihydrate 0.1 M Sodium cacodylate 6.5 1-6 0.1 M Sodium phosphate monobasic monohydrate 1.4 M Sodium acetate trihydrate 0.1 M Sodium cacodylate 6.5 1-7 0.1 M Sodium phosphate monobasic monohydrate 1.7 M Sodium acetate trihydrate 0.1 M Sodium cacodylate 6.5 1-8 1.7 M Sodium acetate trihydrate 0.1 M Sodium cacodylate 6.5 1-9 0.2 M Ammonium acetate 0.1 M Sodium acetate 4.5 8 % w/v PEG 3350 1-10 0.2 M Ammonium acetate 0.1 M Sodium acetate 4.5 15 % w/v PEG 3350 1-11 0.2 M Ammonium acetate 0.1 M Sodium acetate 4.5 20 % w/v PEG 3350 1-12 0.2 M Ammonium acetate 0.1 M Sodium acetate 4.5 30 % w/v PEG 3350 1-13 0.75 M Ammonium phosphate monobasic 0.1 M Sodium citrate 5.5 1-14 1.0 M Ammonium phosphate monobasic 0.1 M Sodium citrate 5.5 1-15 1.5 M Ammonium phosphate monobasic 0.1 M Sodium citrate 5.5 1-16 2.0 M Ammonium phosphate monobasic 0.1 M Sodium citrate 5.5 1-17 0.2 M Magnesium chloride hexahydrate 0.1 M Sodium HEPES 7.5 10 % v/v 2-Propanol 1-18 0.2 M Magnesium chloride hexahydrate 0.1 M Sodium HEPES 7.5 15 % v/v 2-Propanol 1-19 0.2 M Magnesium chloride hexahydrate 0.1 M Sodium HEPES 7.5 20 % v/v 2-Propanol 1-20 0.2 M Magnesium chloride hexahydrate 0.1 M Sodium HEPES 7.5 30 % v/v 2-Propanol 1-21 0.2 M Lithium sulfate 0.1 M Tris 8.5 16 % w/v PEG 3350 1-22 0.2 M Lithium sulfate 0.1 M Tris 8.5 25 % w/v PEG 3350 1-23 0.2 M Lithium sulfate 0.1 M Tris 8.5 30 % w/v PEG 3350 1-24 0.5 M Lithium sulfate 0.1 M Tris 8.5 25 % w/v PEG 3350 2-1 1.0 M Lithium sulfate 2 % w/v PEG 8000 2-2 1.0 M Lithium sulfate 0.1 M Imidazole malate 5.5 2 % w/v PEG 8000 2-3 1.0 M Lithium sulfate 0.1 M Imidazole malate 6.5 2 % w/v PEG 8000 2-4 1.0 M Lithium sulfate 0.1 M Imidazole malate 7.5 2 % w/v PEG 8000 2-5 0.2 M Ammonium sulfate 12 % w/v PEG 8000 2-6 0.2 M Ammonium sulfate 18 % w/v PEG 8000 2-7 0.2 M Ammonium sulfate 24 % w/v PEG 8000 2-8 0.2 M Ammonium sulfate 30 % w/v PEG 8000 2-9 0.5 M Ammonium sulfate 10 % w/v PEG 4000 2-10 0.3 M Ammonium sulfate 20 % w/v PEG 4000 2-11 0.2 M Ammonium sulfate 30 % w/v PEG 4000 2-12 0.2 M Ammonium sulfate 36 % w/v PEG 4000 2-13 1.0 M Ammonium sulfate 0.1 M Sodium HEPES 7.5 2 % v/v PEG 400 2-14 1.5 M Ammonium sulfate 0.1 M Sodium HEPES 7.5 2 % v/v PEG 400 2-15 2.0 M Ammonium sulfate 0.1 M Sodium HEPES 7.5 2 % v/v PEG 400 2-16 2.0 M Ammonium sulfate 0.1 M Sodium HEPES 7.5 5 % v/v PEG 400 2-17 0.1 M Sodium citrate 5.5 12 % w/v PEG 4000 5 % v/v 2-Propanol 2-18 0.1 M Sodium citrate 5.5 16 % w/v PEG 4000 10 % v/v 2-Propanol 2-19 0.1 M Sodium citrate 5.5 20 % w/v PEG 4000 15 % v/v 2-Propanol 2-20 0.1 M Sodium citrate 5.5 20 % w/v PEG 4000 20 % v/v 2-Propanol 2-21 0.005 M Zinc acetate dihydrate 0.1 M Sodium cacodylate 6.5 9 % w/v PEG 8000 2-22 0.005 M Zinc acetate dihydrate 0.1 M Sodium cacodylate 6.5 12 % w/v PEG 8000 2-23 0.005 M Zinc acetate dihydrate 0.1 M Sodium cacodylate 6.5 18 % w/v PEG 8000 2-24 0.005 M Zinc acetate dihydrate 0.1 M Sodium cacodylate 6.5 24 % w/v PEG 8000 Abbreviations: Sodium HEPES; 2-(4-(2-Hydroxyethyl)-1-piperazinyl)ethanesulfonic Acid Sodium Salt, MPD; 2-Methyl-2,4-pentanediol, PEG; Polyethylene glycol, Tris; 2-Amino-2-(hydroxymethyl)propane-1,3-diol, Manufacturer s safety data sheets are available from our website or by scanning the QR code here: 3